Stay updated on RMC-6236 in RAS Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.

Latest updates to the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedFooter revision label updated to Revision: v3.5.2. The previous Revision: v3.5.0 entry was removed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated to v3.4.3. Previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded a publication entry for the 2024 article Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers and removed the Erratum entry for that article.SummaryDifference0.0%

- Check71 days agoChange DetectedAdded Revision: v3.4.2 and removed the notices for v3.4.1 and the government funding lapse message. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check78 days agoChange DetectedA site-wide funding-status notice was added, and the Publications section was updated to include an Erratum for the Cancer Discovery article and a new citation, replacing the prior reference.SummaryDifference0.4%

Stay in the know with updates to RMC-6236 in RAS Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.